Bremelanotide is administered via a subcutaneous injection, typically given in the abdomen or thigh. It is intended for use on an as-needed basis, approximately 45 minutes before anticipated sexual activity. Patients should not use more than one dose within a 24-hour period or more than eight doses per month.
